Andreas Cser

Partner at Fraser

📍 London, England Metropolitan Area, United Kingdom🔄 Updated September 2026💼 8 investments📅 18 years investing🗓 Last invested Feb 2018𝕏 @upgrade_to_unlock
VC🌍 United Kingdom
8
Total investments
5
Early stage
2
Mid stage
0
Late stage
18y
Years active

Portfolio

8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor, Board Member
Feb 2018
Bidnamic combines advanced machine learning with human expertise to drive revenue and profits from Google Shopping adverts. We work with ecommerce companies to maximise the potential of every product, whether they have hundreds or hundreds of thousands of SKUs, which is beyond what humans can manage manually. Using advanced machine learning algorithms our platform predicts the right price to pay for each Google Shopping click, 24 hours a day 365 days a year, making it possible for our clients to outperform their competitors and drive profitable revenues from search marketing. Clients use data generated from our platform to predict inventory needs and identify growth opportunities across all channels, making proactive data-driven decisions to secure the sustainable growth of their business.
Investor, Advisor
Dec 2016
Making kids’ food super is what drives us. Super means better, super means less processed, super means utilising the latest in food science. With our in-house team of nutritionists, chemists and food technologists, we develop products with both nutritional value and sustainability in mind. Because we want to create products for many generations to come. All our products are 100% plant-based and developed specifically for the nutritional requirements of kids. As a business, we have a clear mission to measure our impact on the planet through indicators such as food waste, packaging and CO₂ emissions. For more information see https://mia-ben.com/responsibility/. Mia & Ben was founded in 2016 and now has 15 employees based in both Berlin and London. We are currently available in the fridges of major online and offline retailers in the United Kingdom and Germany with lots more to come.
Investor, Advisor
Jul 2016
Pathfinder Medical is a medical device company, spun out of Imperial College in 2014, which is developing an electronic catheter guidance technology that enables completely new types of endovascular procedures to be performed. Pathfinder Medical is developing a novel electronic guidance system that will enable clinicians to connect blood vessels in a minimally invasive way. This platform technology has a variety of clinical applications such as bypassing peripheral blockages and in vascular access creation for dialysis patients, which represents a £1.6b yearly market. Clinical Need Diabetes and high blood pressure are the most prevalent causes of kidney disease. Worldwide 3.4 million patients have end stage kidney disease and require their blood to be routinely filtered externally through haemodialysis. In US, the number of patients with kidney failure grows by 5% annually. In addition to renal failure, diabetes and high blood pressure are also major causes for peripheral arterial disease with 200 million patients globally. The most severe manifestation of the disease affects up to 30 million patients, with almost half of them at risk for amputation in the first year. Open surgery is the current standard for preparing patients for dialysis and bypassing blocked peripheral arteries. In both cases, blood vessels are connected to form either a short circuit to form a vascular access site for dialysis (AV fistulas) or bypass a blockage in a vessel. High failure rates (approximately 50%) in both cases present a serious danger to life and require repeat procedures (as many as 3.4 per patient year for dialysis patients) which cost over $4.6 billion in the US.
Investor, Board Member
May 2016
Discover great designs from independent artists, across a range of beautifully made products. Dizinga supports artists worldwide.
Investor, Advisor
Mar 2012
Zonga is the first legal music platform in Romania, partnered with all the major international and local music labels to legally provide a music catalog of over 36 million songs. Main Features - Play music from a catalog of over 36 million songs, having a great structure on artists, albums, playlist or genre; - Online playback on all your devices, with no advertising what so ever on premium price plan; - Offline playback, to you listen to your favorite music on the go, with no internet connectivity; - Charts & curated playlists to help you discover new sounds or artists; - Recommendations based on your music activity; - Create playlists and build your favorites collection; - Share music with your friends on Facebook, Twitter etc. On All Your Devices - PC or Mac (browser) - iOS devices (iPhone, iPad, iPod Touch) - Android devices (smartphones & tablets) The easiest new way to listen and enjoy all your favorite music, anytime you like, on all your devices!
early stageMusicians
Investor, Advisor
Jan 2012
Jampp is a programmatic advertising platform used by the most ambitious companies to accelerate their mobile businesses. Founded in 2013, Jampp leverages machine learning, creative optimization and proprietary advertising solutions to drive incremental growth for its customers, whether that means reaching new users or increasing post-install conversions. In 2021, the company joined the Affle group, a global consumer intelligence technology company. For more information, visit jampp.com
Advisor, Investor
Jan 2010
Trilulilu is the largest online community in Romania where people can watch and listen to videos, music and photos. Trilulilu was founded in 2007 and currently has over 650,000 registered users. It is one of the most visited websites in Romania with more than 2.3 million unique visitors per month.
Partner, Lead Co-investments
Apr 2008
We are a dedicated M&A advisory and investment firm, partnering with leaders in Europe’s B2B technology sectors to unlock next levels of growth & success. Based in Berlin, London, and Chicago, we advise entrepreneurs, senior management and boards on their most important strategic decisions and transactions. Alongside our clients and partners, we also invest into selected opportunities. Since 2005, we have completed over $1.5BN worth of digital M&A and financing transactions, incl. ADTECH AG (acquired by AOL), 3GNet GmbH (acquired by iCrossing and subsequently sold to Hearst), UDG (backed with $100M+ by EQT and then merged with PIA Performance Interactive Alliance), nugg.ad AG (acquired by Deutsche Post DHL and then sold to Zalando), Optivo GmbH (acquired by Deutsche Post DHL), explido GmbH (acquired by Dentsu and combined to form explido iProspect), Adglow (acquisition of Glow), Episerver AB (acquisition of Optivo GmbH, backed by Accel-KKR), Tessian (backed by Sequoia), diffferent GmbH (acquired by Syzygy, part of WPP), and Systemiq (backed by Lombard Odier).
Experience · 11 entries
All (11)
Investments (8)
Founder (1)
Board (2)
2018
Partner
May 2018
We invest in Automation
Investor, Board Member
Feb 2018
Bidnamic combines advanced machine learning with human expertise to drive revenue and profits from Google Shopping adverts. We work with ecommerce companies to maximise the potential of every product, whether they have hundreds or hundreds of thousands of SKUs, which is beyond what humans can manage manually. Using advanced machine learning algorithms our platform predicts the right price to pay for each Google Shopping click, 24 hours a day 365 days a year, making it possible for our clients to outperform their competitors and drive profitable revenues from search marketing. Clients use data generated from our platform to predict inventory needs and identify growth opportunities across all channels, making proactive data-driven decisions to secure the sustainable growth of their business.
2016
Investor, Advisor
Dec 2016
Making kids’ food super is what drives us. Super means better, super means less processed, super means utilising the latest in food science. With our in-house team of nutritionists, chemists and food technologists, we develop products with both nutritional value and sustainability in mind. Because we want to create products for many generations to come. All our products are 100% plant-based and developed specifically for the nutritional requirements of kids. As a business, we have a clear mission to measure our impact on the planet through indicators such as food waste, packaging and CO₂ emissions. For more information see https://mia-ben.com/responsibility/. Mia & Ben was founded in 2016 and now has 15 employees based in both Berlin and London. We are currently available in the fridges of major online and offline retailers in the United Kingdom and Germany with lots more to come.
Investor, Advisor
Jul 2016
Pathfinder Medical is a medical device company, spun out of Imperial College in 2014, which is developing an electronic catheter guidance technology that enables completely new types of endovascular procedures to be performed. Pathfinder Medical is developing a novel electronic guidance system that will enable clinicians to connect blood vessels in a minimally invasive way. This platform technology has a variety of clinical applications such as bypassing peripheral blockages and in vascular access creation for dialysis patients, which represents a £1.6b yearly market. Clinical Need Diabetes and high blood pressure are the most prevalent causes of kidney disease. Worldwide 3.4 million patients have end stage kidney disease and require their blood to be routinely filtered externally through haemodialysis. In US, the number of patients with kidney failure grows by 5% annually. In addition to renal failure, diabetes and high blood pressure are also major causes for peripheral arterial disease with 200 million patients globally. The most severe manifestation of the disease affects up to 30 million patients, with almost half of them at risk for amputation in the first year. Open surgery is the current standard for preparing patients for dialysis and bypassing blocked peripheral arteries. In both cases, blood vessels are connected to form either a short circuit to form a vascular access site for dialysis (AV fistulas) or bypass a blockage in a vessel. High failure rates (approximately 50%) in both cases present a serious danger to life and require repeat procedures (as many as 3.4 per patient year for dialysis patients) which cost over $4.6 billion in the US.
Investor, Board Member
May 2016
Discover great designs from independent artists, across a range of beautifully made products. Dizinga supports artists worldwide.
Show all 11 entries ↓
Investment activity
2008–2018 · 8 investments
2008120101201222016320181
Recent (last 2 years)Earlier